Successful use of lenalidomide to treat refractory acquired von Willebrand disease associated with monoclonal gammopathy.

Authors:
Green A; Shen YP; Nelson AT; Sarode R; Ibrahim IF and 3 more

Journal:
Ann Hematol

Publication Year: 2022

DOI:
10.1007/s00277-022-04991-9

PMCID:
PMC9530414

PMID:
36194257

Journal Information

Full Title: Ann Hematol

Abbreviation: Ann Hematol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approvalThis article does not contain any studies with human participants or animals. Consent to participateInformed consent was obtained from the individual described in this manuscript. Conflict of interestThe authors declare no competing interests. Conflict of interest The authors declare no competing interests."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025